Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Patient Information Leaflet last updated on the eMC: 11/10/2011
PIL Exforge 10mg/160mg film coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/10/2011 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 22/08/2011 and displayed until 11/10/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 27/05/2009 and displayed until 22/08/2011
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
Updated on 01/05/2009 and displayed until 27/05/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 30/07/2008 and displayed until 01/05/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to information about pregnancy or lactation
Updated on 12/02/2007 and displayed until 30/07/2008
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   valsartan
   amlodipine besilate